Study details
Enrolling now
Long-Term COVID and Rehabilitation Trial
VA Office of Research and Development
NCT IDNCT05373043ClinicalTrials.gov data as of Apr 2026
Target enrollment
300
Study length
about 6 years
Ages
50+
Locations
1 site in UT
About this study
Researchers are testing whether Mitoquinone, a dietary supplement, helps improve vascular endothelial function in adults recovering from long-COVID. The trial will last for 2191 days and involve approximately 300 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Mitoquinone
- 2.Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.